ITCC-079 Lynparza
A Phase I, Open-label, Parallel Group Study to Investigate Olaparib Safety and Tolerability, Efficacy and Pharmacokinetics in Paediatric Patients (aged 6 months to 17 years) with Solid Tumours
Promotor Name : AstraZeneca
Investigator Name : Dr Birgit GEOERGER
Trial registered on clinicaltrial.gov: NCT04236414
